ALOX5AP and non-small cell lung carcinoma: Analysis of data from 1,926 NSCLC patients showed a trend of high FLAP expression correlating with a lower overall probability of survival, but this was not statistically significant (P = 0.15, HR = 1.1) (Figure 1A).